A Multicenter, Follow-Up Study to Assess Long-Term Electrophysiologic and Clinical Outcomes in Subjects Previously Enrolled in Study 215ON201

Trial Profile

A Multicenter, Follow-Up Study to Assess Long-Term Electrophysiologic and Clinical Outcomes in Subjects Previously Enrolled in Study 215ON201

Completed
Phase of Trial: Phase II

Latest Information Update: 15 May 2017

At a glance

  • Drugs Opicinumab (Primary)
  • Indications Optic neuritis
  • Focus Pharmacodynamics
  • Acronyms RENEWed
  • Sponsors Biogen
  • Most Recent Events

    • 24 Feb 2017 Status changed from recruiting to completed.
    • 17 Feb 2017 This trial has been completed in Hungary (end date: 2017-01-23).
    • 23 Jan 2017 Planned End Date changed from 1 Feb 2017 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top